novo glp 1 drugs inks Ascendis deal to develop long-acting GLP-1, other metabolic Wegovy pill: With FDA approval,
Description
Weight loss may plateau, blood glucose targets remain out of reach, or side effects limit long-term use
Research from the STEP 1 trial found that a meaningful portion of weight lost on semaglutide came from lean mass, not just fat
Intro to Greek lyric poetry
doi: 10.2337/db11-0489
One of those medications, Wegovy, is also FDA-approved for the treatment of cardiovascular disease
Its also quite effective in controlling blood sugar
